<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>Myeloma OutlookCAST</title>
    <link>http://www.lls.org</link>
    <description>Podcast for those living with myeloma. Sponsored by The Leukemia &amp; Lymphoma Society</description>
    <copyright>(c)2008</copyright>
    <managingEditor>admin@lls.org (admin@lls.org)</managingEditor>
    <language>en-us</language>
    <lastBuildDate>Sat, 25 May 2013 16:09:32 GMT</lastBuildDate>
    <generator>Hipcast RSS Feeder 1.25</generator>
    <category>Health &amp; Fitness</category>
    <atom:link href="http://lls.hipcast.com/rss/myeloma_outlook.xml" rel="self" type="application/rss+xml"/>
    <ttl>60</ttl>
    <image>
      <url>http://lls.hipcast.com/albumart/1008.1369498172.jpg</url>
      <link>http://www.lls.org</link>
      <title>Myeloma OutlookCAST</title>
    </image>
    <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
    <itunes:summary>Podcast for those living with myeloma. Sponsored by The Leukemia &amp; Lymphoma Society</itunes:summary>
    <itunes:subtitle></itunes:subtitle>
    <itunes:explicit>no</itunes:explicit>
    <itunes:keywords>myeloma,cancer</itunes:keywords>
    <itunes:owner>
      <itunes:name>Samantha Mills</itunes:name>
      <itunes:email>admin@leukemia-lymphoma.org</itunes:email>
    </itunes:owner>
    <itunes:image href="http://lls.hipcast.com/albumart/1008.1369498172.jpg"/>
    <itunes:category text="Health"/>
    <itunes:category text="Science &amp; Medicine">
      <itunes:category text="Medicine"/>
    </itunes:category>
    <item>
      <guid isPermaLink="false">229fdee9-a76a-f07e-9965-255b4662b0ed</guid>
      <title>Blood Cancer Treatment - Making Informed Choices - Part 1</title>
      <description><![CDATA[Date: February 26, 2013

Speaker: Stephen D. Nimer, MD

Topics:
Understanding goals of treatment for your diagnosis
Understanding your treatment options
Benefits and risks for standard treatments and investigational treatments
Key facts about clinical trials]]></description>
      <pubDate>Fri, 05 Apr 2013 20:33:51 GMT</pubDate>
      <itunes:duration>00:40:24</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Date: February 26, 2013&#13;
&#13;
Speaker: Stephen D. Nimer, MD&#13;
&#13;
Topics:&#13;
Understanding goals of treatment for your diagnosis&#13;
Understanding your treatment options&#13;
Benefits and risks for standard treatments and investigational treatments&#13;
Key facts about clinical trials</itunes:summary>
      <itunes:subtitle>Blood Cancer Treatment - Making Informed Choices - Part 1</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/90f6f90f-8cb8-c292-8f35-031af4837b4d.mp3" type="audio/mpeg" length="9697545"/>
      <media:title>Blood Cancer Treatment - Making Informed Choices - Part 1</media:title>
      <media:text type="plain">Date: February 26, 2013&#13;
&#13;
Speaker: Stephen D. Nimer, MD&#13;
&#13;
Topics:&#13;
Understanding goals of treatment for your diagnosis&#13;
Understanding your treatment options&#13;
Benefits and risks for standard treatments and investigational treatments&#13;
Key facts about clinical trials</media:text>
      <media:content url="http://lls.hipcast.com/deluge/90f6f90f-8cb8-c292-8f35-031af4837b4d.mp3" type="audio/mpeg" fileSize="9697545" duration="2424"/>
      <link>http://lls.hipcast.com/deluge/90f6f90f-8cb8-c292-8f35-031af4837b4d.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">e07a7fff-b4bd-8a39-a047-242679aa4c57</guid>
      <title>Blood Cancer Treatment - Making Informed Choices - Part 2</title>
      <description><![CDATA[Date: February 26, 2013

Speaker: Stephen D. Nimer, MD

Topics:
Understanding goals of treatment for your diagnosis
Understanding your treatment options
Benefits and risks for standard treatments and investigational treatments
Key facts about clinical trials]]></description>
      <pubDate>Fri, 05 Apr 2013 20:33:21 GMT</pubDate>
      <itunes:duration>00:14:31</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Date: February 26, 2013&#13;
&#13;
Speaker: Stephen D. Nimer, MD&#13;
&#13;
Topics:&#13;
Understanding goals of treatment for your diagnosis&#13;
Understanding your treatment options&#13;
Benefits and risks for standard treatments and investigational treatments&#13;
Key facts about clinical trials</itunes:summary>
      <itunes:subtitle>Blood Cancer Treatment - Making Informed Choices - Part 2</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/6fe49280-bd63-156f-1654-24aa83296fbd.mp3" type="audio/mpeg" length="3485940"/>
      <media:title>Blood Cancer Treatment - Making Informed Choices - Part 2</media:title>
      <media:text type="plain">Date: February 26, 2013&#13;
&#13;
Speaker: Stephen D. Nimer, MD&#13;
&#13;
Topics:&#13;
Understanding goals of treatment for your diagnosis&#13;
Understanding your treatment options&#13;
Benefits and risks for standard treatments and investigational treatments&#13;
Key facts about clinical trials</media:text>
      <media:content url="http://lls.hipcast.com/deluge/6fe49280-bd63-156f-1654-24aa83296fbd.mp3" type="audio/mpeg" fileSize="3485940" duration="871"/>
      <link>http://lls.hipcast.com/deluge/6fe49280-bd63-156f-1654-24aa83296fbd.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">f01399bd-4386-bc47-9d05-73e995c76f68</guid>
      <title>Myeloma-The Latest on Research and Treatment from ASH Part 2</title>
      <description><![CDATA[Date: January 29, 2013

Speaker: Kenneth C. Anderson, MD

Topics:
Updates about current and emerging myeloma treatment options 
Updates in myeloma maintenance therapy 
The role of clinical trials in the advancement of myeloma treatment 
Advances in myeloma treatment side effects management]]></description>
      <pubDate>Fri, 01 Mar 2013 15:23:45 GMT</pubDate>
      <itunes:duration>00:38:10</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Date: January 29, 2013&#13;
&#13;
Speaker: Kenneth C. Anderson, MD&#13;
&#13;
Topics:&#13;
Updates about current and emerging myeloma treatment options &#13;
Updates in myeloma maintenance therapy &#13;
The role of clinical trials in the advancement of myeloma treatment &#13;
Advances in myeloma treatment side effects management</itunes:summary>
      <itunes:subtitle>Myeloma-The Latest on Research and Treatment from ASH Part 2</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/13eaf33e-8cd8-7fe5-c482-2cc2a77812c4.mp3" type="audio/mpeg" length="9164474"/>
      <media:title>Myeloma-The Latest on Research and Treatment from ASH Part 2</media:title>
      <media:text type="plain">Date: January 29, 2013&#13;
&#13;
Speaker: Kenneth C. Anderson, MD&#13;
&#13;
Topics:&#13;
Updates about current and emerging myeloma treatment options &#13;
Updates in myeloma maintenance therapy &#13;
The role of clinical trials in the advancement of myeloma treatment &#13;
Advances in myeloma treatment side effects management</media:text>
      <media:content url="http://lls.hipcast.com/deluge/13eaf33e-8cd8-7fe5-c482-2cc2a77812c4.mp3" type="audio/mpeg" fileSize="9164474" duration="2290"/>
      <link>http://lls.hipcast.com/deluge/13eaf33e-8cd8-7fe5-c482-2cc2a77812c4.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">e5cc11ee-4bf4-432b-ab22-8c3719aeb756</guid>
      <title>Myeloma-The Latest on Research and Treatment from ASH Part 1</title>
      <description><![CDATA[Date: January 29, 2013

Speaker: Kenneth C. Anderson, MD

Topics:
Updates about current and emerging myeloma treatment options 
Updates in myeloma maintenance therapy 
The role of clinical trials in the advancement of myeloma treatment 
Advances in myeloma treatment side effects management]]></description>
      <pubDate>Fri, 01 Mar 2013 15:19:40 GMT</pubDate>
      <itunes:duration>00:49:29</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Date: January 29, 2013&#13;
&#13;
Speaker: Kenneth C. Anderson, MD&#13;
&#13;
Topics:&#13;
Updates about current and emerging myeloma treatment options &#13;
Updates in myeloma maintenance therapy &#13;
The role of clinical trials in the advancement of myeloma treatment &#13;
Advances in myeloma treatment side effects management</itunes:summary>
      <itunes:subtitle>Myeloma-The Latest on Research and Treatment from ASH Part 1</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/cfcc2f11-c0e6-2762-0a1d-8a6e0eff8296.mp3" type="audio/mpeg" length="11881835"/>
      <media:title>Myeloma-The Latest on Research and Treatment from ASH Part 1</media:title>
      <media:text type="plain">Date: January 29, 2013&#13;
&#13;
Speaker: Kenneth C. Anderson, MD&#13;
&#13;
Topics:&#13;
Updates about current and emerging myeloma treatment options &#13;
Updates in myeloma maintenance therapy &#13;
The role of clinical trials in the advancement of myeloma treatment &#13;
Advances in myeloma treatment side effects management</media:text>
      <media:content url="http://lls.hipcast.com/deluge/cfcc2f11-c0e6-2762-0a1d-8a6e0eff8296.mp3" type="audio/mpeg" fileSize="11881835" duration="2969"/>
      <link>http://lls.hipcast.com/deluge/cfcc2f11-c0e6-2762-0a1d-8a6e0eff8296.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">67205eed-244f-aa24-9a13-4ee3e987784c</guid>
      <title>Update: ASCT for Lymphoma and Myeloma Part 2</title>
      <description><![CDATA[Speakers: Jonathan W. Friedberg, MD, MMSc; Edward A. Stadtmauer, MD

Topics:
The role of autologous stem cell transplantation (ASCT) to treat patients with myeloma
The role of ASCT to treat patients with lymphoma
Side effects management and other quality of life issues for ASCT patients
Key ASCT research topics
The importance of patient-provider communications]]></description>
      <pubDate>Tue, 08 Jan 2013 20:29:35 GMT</pubDate>
      <itunes:duration>00:21:32</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Speakers: Jonathan W. Friedberg, MD, MMSc; Edward A. Stadtmauer, MD&#13;
&#13;
Topics:&#13;
The role of autologous stem cell transplantation (ASCT) to treat patients with myeloma&#13;
The role of ASCT to treat patients with lymphoma&#13;
Side effects management and other quality of life issues for ASCT patients&#13;
Key ASCT research topics&#13;
The importance of patient-provider communications</itunes:summary>
      <itunes:subtitle>Update: ASCT for Lymphoma and Myeloma Part 2</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/19f43451-7f43-17a7-2828-d9db565fbbe9.mp3" type="audio/mpeg" length="5168611"/>
      <media:title>Update: ASCT for Lymphoma and Myeloma Part 2</media:title>
      <media:text type="plain">Speakers: Jonathan W. Friedberg, MD, MMSc; Edward A. Stadtmauer, MD&#13;
&#13;
Topics:&#13;
The role of autologous stem cell transplantation (ASCT) to treat patients with myeloma&#13;
The role of ASCT to treat patients with lymphoma&#13;
Side effects management and other quality of life issues for ASCT patients&#13;
Key ASCT research topics&#13;
The importance of patient-provider communications</media:text>
      <media:content url="http://lls.hipcast.com/deluge/19f43451-7f43-17a7-2828-d9db565fbbe9.mp3" type="audio/mpeg" fileSize="5168611" duration="1292"/>
      <link>http://lls.hipcast.com/deluge/19f43451-7f43-17a7-2828-d9db565fbbe9.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">faeaa435-82cc-8fef-4e3f-d1d9b6337661</guid>
      <title>Update: ASCT for Lymphoma and Myeloma Part 1</title>
      <description><![CDATA[Speakers: Jonathan W. Friedberg, MD, MMSc; Edward A. Stadtmauer, MD

Topics:
The role of autologous stem cell transplantation (ASCT) to treat patients with myeloma
The role of ASCT to treat patients with lymphoma
Side effects management and other quality of life issues for ASCT patients
Key ASCT research topics
The importance of patient-provider communications]]></description>
      <pubDate>Tue, 08 Jan 2013 20:28:59 GMT</pubDate>
      <itunes:duration>00:38:51</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Speakers: Jonathan W. Friedberg, MD, MMSc; Edward A. Stadtmauer, MD&#13;
&#13;
Topics:&#13;
The role of autologous stem cell transplantation (ASCT) to treat patients with myeloma&#13;
The role of ASCT to treat patients with lymphoma&#13;
Side effects management and other quality of life issues for ASCT patients&#13;
Key ASCT research topics&#13;
The importance of patient-provider communications</itunes:summary>
      <itunes:subtitle>Update: ASCT for Lymphoma and Myeloma Part 1</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/bc8da6b8-0758-e381-c23c-2518cc57d1cc.mp3" type="audio/mpeg" length="9325633"/>
      <media:title>Update: ASCT for Lymphoma and Myeloma Part 1</media:title>
      <media:text type="plain">Speakers: Jonathan W. Friedberg, MD, MMSc; Edward A. Stadtmauer, MD&#13;
&#13;
Topics:&#13;
The role of autologous stem cell transplantation (ASCT) to treat patients with myeloma&#13;
The role of ASCT to treat patients with lymphoma&#13;
Side effects management and other quality of life issues for ASCT patients&#13;
Key ASCT research topics&#13;
The importance of patient-provider communications</media:text>
      <media:content url="http://lls.hipcast.com/deluge/bc8da6b8-0758-e381-c23c-2518cc57d1cc.mp3" type="audio/mpeg" fileSize="9325633" duration="2331"/>
      <link>http://lls.hipcast.com/deluge/bc8da6b8-0758-e381-c23c-2518cc57d1cc.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">079cb3c8-adbf-2cc4-9277-18de32095207</guid>
      <title>Myeloma - Diagnosis and Treatment Update Part 2</title>
      <description><![CDATA[Speaker: Ruben Niesvizky,MD
Topics Covered: -Goals of myeloma treatment -Current treatments and emerging therapies, including updates on stem cell transplantation and maintenance therapy -Updates on side effects management -The importance of patient and healthcare team communications]]></description>
      <pubDate>Mon, 17 Dec 2012 18:41:00 GMT</pubDate>
      <itunes:duration>00:37:26</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Speaker: Ruben Niesvizky,MD&#13;
Topics Covered: -Goals of myeloma treatment -Current treatments and emerging therapies, including updates on stem cell transplantation and maintenance therapy -Updates on side effects management -The importance of patient and healthcare team communications</itunes:summary>
      <itunes:subtitle>Myeloma - Diagnosis and Treatment Update Part 2</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/9a1baed3-7383-b8ae-7b62-d7972c5fcb59.mp3" type="audio/mpeg" length="8988155"/>
      <media:title>Myeloma - Diagnosis and Treatment Update Part 2</media:title>
      <media:text type="plain">Speaker: Ruben Niesvizky,MD&#13;
Topics Covered: -Goals of myeloma treatment -Current treatments and emerging therapies, including updates on stem cell transplantation and maintenance therapy -Updates on side effects management -The importance of patient and healthcare team communications</media:text>
      <media:content url="http://lls.hipcast.com/deluge/9a1baed3-7383-b8ae-7b62-d7972c5fcb59.mp3" type="audio/mpeg" fileSize="8988155" duration="2246"/>
      <link>http://lls.hipcast.com/deluge/9a1baed3-7383-b8ae-7b62-d7972c5fcb59.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">978b57cc-62dd-21c7-4df8-48dac3a86686</guid>
      <title>Myeloma - Diagnosis and Treatment Update Part 1</title>
      <description><![CDATA[Speaker: Ruben Niesvizky,MD
Topics Covered: -Goals of myeloma treatment -Current treatments and emerging therapies, including updates on stem cell transplantation and maintenance therapy -Updates on side effects management -The importance of patient and healthcare team communications]]></description>
      <pubDate>Mon, 17 Dec 2012 18:39:54 GMT</pubDate>
      <itunes:duration>00:50:36</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Speaker: Ruben Niesvizky,MD&#13;
Topics Covered: -Goals of myeloma treatment -Current treatments and emerging therapies, including updates on stem cell transplantation and maintenance therapy -Updates on side effects management -The importance of patient and healthcare team communications</itunes:summary>
      <itunes:subtitle>Myeloma - Diagnosis and Treatment Update Part 1</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/5dcfcb70-221e-2b9c-88bf-7ca45fd8c648.mp3" type="audio/mpeg" length="12147434"/>
      <media:title>Myeloma - Diagnosis and Treatment Update Part 1</media:title>
      <media:text type="plain">Speaker: Ruben Niesvizky,MD&#13;
Topics Covered: -Goals of myeloma treatment -Current treatments and emerging therapies, including updates on stem cell transplantation and maintenance therapy -Updates on side effects management -The importance of patient and healthcare team communications</media:text>
      <media:content url="http://lls.hipcast.com/deluge/5dcfcb70-221e-2b9c-88bf-7ca45fd8c648.mp3" type="audio/mpeg" fileSize="12147434" duration="3036"/>
      <link>http://lls.hipcast.com/deluge/5dcfcb70-221e-2b9c-88bf-7ca45fd8c648.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">4b4af69d-cd2b-6a2a-c1ce-2cba884b56c2</guid>
      <title>Myeloma Treatment and Side Effects Management Update Spanish</title>
      <description><![CDATA[Speakers: Melissa Alsina, MD and Kathy A. Daily, RN, OCN; Topics Covered: - Current and emerging treatment options for myeloma, - The importance of clinical trials in improving myeloma patient outcomes, - Possible myeloma symptoms and treatment for side effects management, - Survivorship issues for people living with myeloma]]></description>
      <pubDate>Thu, 12 Jul 2012 20:01:27 GMT</pubDate>
      <itunes:duration>01:38:18</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Speakers: Melissa Alsina, MD and Kathy A. Daily, RN, OCN; Topics Covered: - Current and emerging treatment options for myeloma, - The importance of clinical trials in improving myeloma patient outcomes, - Possible myeloma symptoms and treatment for side effects management, - Survivorship issues for people living with myeloma</itunes:summary>
      <itunes:subtitle>Myeloma Treatment and Side Effects Management Update Spanish</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/dc56a564-c9fe-e808-a410-b72c5b768ab2.mp3" type="audio/mpeg" length="47189307"/>
      <media:title>Myeloma Treatment and Side Effects Management Update Spanish</media:title>
      <media:text type="plain">Speakers: Melissa Alsina, MD and Kathy A. Daily, RN, OCN; Topics Covered: - Current and emerging treatment options for myeloma, - The importance of clinical trials in improving myeloma patient outcomes, - Possible myeloma symptoms and treatment for side effects management, - Survivorship issues for people living with myeloma</media:text>
      <media:content url="http://lls.hipcast.com/deluge/dc56a564-c9fe-e808-a410-b72c5b768ab2.mp3" type="audio/mpeg" fileSize="47189307" duration="5898"/>
      <link>http://lls.hipcast.com/deluge/dc56a564-c9fe-e808-a410-b72c5b768ab2.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">960c5a06-ebe9-0760-e066-898b2199cad9</guid>
      <title>Myeloma Treatment and Side Effects Management Update Part 1</title>
      <description><![CDATA[Speakers: Melissa Alsina, MD and Kathy A. Daily, RN, OCN; Topics Covered: - Current and emerging treatment options for myeloma, - The importance of clinical trials in improving myeloma patient outcomes, - Possible myeloma symptoms and treatment for side effects management, - Survivorship issues for people living with myeloma]]></description>
      <pubDate>Tue, 19 Jun 2012 02:03:33 GMT</pubDate>
      <itunes:duration>00:53:12</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Speakers: Melissa Alsina, MD and Kathy A. Daily, RN, OCN; Topics Covered: - Current and emerging treatment options for myeloma, - The importance of clinical trials in improving myeloma patient outcomes, - Possible myeloma symptoms and treatment for side effects management, - Survivorship issues for people living with myeloma</itunes:summary>
      <itunes:subtitle>Myeloma Treatment and Side Effects Management Update Part 1</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/8798beef-8be8-b1dd-daca-1d701d9046eb.mp3" type="audio/mpeg" length="25539388"/>
      <media:title>Myeloma Treatment and Side Effects Management Update Part 1</media:title>
      <media:text type="plain">Speakers: Melissa Alsina, MD and Kathy A. Daily, RN, OCN; Topics Covered: - Current and emerging treatment options for myeloma, - The importance of clinical trials in improving myeloma patient outcomes, - Possible myeloma symptoms and treatment for side effects management, - Survivorship issues for people living with myeloma</media:text>
      <media:content url="http://lls.hipcast.com/deluge/8798beef-8be8-b1dd-daca-1d701d9046eb.mp3" type="audio/mpeg" fileSize="25539388" duration="3192"/>
      <link>http://lls.hipcast.com/deluge/8798beef-8be8-b1dd-daca-1d701d9046eb.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">272cb225-3e18-3c2a-1162-ac200656a859</guid>
      <title>Myeloma Treatment and Side Effects Management Update Part 2</title>
      <description><![CDATA[Speakers: Melissa Alsina, MD and Kathy A. Daily, RN, OCN; Topics Covered: - Current and emerging treatment options for myeloma, - The importance of clinical trials in improving myeloma patient outcomes, - Possible myeloma symptoms and treatment for side effects management, - Survivorship issues for people living with myeloma]]></description>
      <pubDate>Tue, 19 Jun 2012 02:03:07 GMT</pubDate>
      <itunes:duration>00:34:52</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Speakers: Melissa Alsina, MD and Kathy A. Daily, RN, OCN; Topics Covered: - Current and emerging treatment options for myeloma, - The importance of clinical trials in improving myeloma patient outcomes, - Possible myeloma symptoms and treatment for side effects management, - Survivorship issues for people living with myeloma</itunes:summary>
      <itunes:subtitle>Myeloma Treatment and Side Effects Management Update Part 2</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/a506bcd2-580c-1be0-d874-f866be9d8a8c.mp3" type="audio/mpeg" length="16738630"/>
      <media:title>Myeloma Treatment and Side Effects Management Update Part 2</media:title>
      <media:text type="plain">Speakers: Melissa Alsina, MD and Kathy A. Daily, RN, OCN; Topics Covered: - Current and emerging treatment options for myeloma, - The importance of clinical trials in improving myeloma patient outcomes, - Possible myeloma symptoms and treatment for side effects management, - Survivorship issues for people living with myeloma</media:text>
      <media:content url="http://lls.hipcast.com/deluge/a506bcd2-580c-1be0-d874-f866be9d8a8c.mp3" type="audio/mpeg" fileSize="16738630" duration="2092"/>
      <link>http://lls.hipcast.com/deluge/a506bcd2-580c-1be0-d874-f866be9d8a8c.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">9cd19ad1-bf7d-6d33-d396-87c9a75267b9</guid>
      <title>Myeloma - Expert Information Spanish</title>
      <description><![CDATA[Topics Covered:  - Signs and symptoms of myeloma; - Diagnosis and staging of myeloma; - Current and emerging treatments for myeloma; - The role of clinical trials in the advancement of myeloma treatment; - Quality of life issues for individuals living with myeloma]]></description>
      <pubDate>Tue, 24 Apr 2012 01:24:48 GMT</pubDate>
      <itunes:duration>01:31:47</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Topics Covered:  - Signs and symptoms of myeloma; - Diagnosis and staging of myeloma; - Current and emerging treatments for myeloma; - The role of clinical trials in the advancement of myeloma treatment; - Quality of life issues for individuals living with myeloma</itunes:summary>
      <itunes:subtitle>Myeloma - Expert Information Spanish</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/1adfa98e-8c41-7ea3-50ad-32a5468707a3.mp3" type="audio/mpeg" length="22033597"/>
      <media:title>Myeloma - Expert Information Spanish</media:title>
      <media:text type="plain">Topics Covered:  - Signs and symptoms of myeloma; - Diagnosis and staging of myeloma; - Current and emerging treatments for myeloma; - The role of clinical trials in the advancement of myeloma treatment; - Quality of life issues for individuals living with myeloma</media:text>
      <media:content url="http://lls.hipcast.com/deluge/1adfa98e-8c41-7ea3-50ad-32a5468707a3.mp3" type="audio/mpeg" fileSize="22033597" duration="5507"/>
      <link>http://lls.hipcast.com/deluge/1adfa98e-8c41-7ea3-50ad-32a5468707a3.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">7d47c5f5-2e72-b141-d8f9-3e19ccde220d</guid>
      <title>Myeloma - Updates from the ASH Annual Meeting Spanish</title>
      <description><![CDATA[Speaker: Robert Z. Orlowski,MD, PhD; Topics Covered: - Goals of myeloma treatment - Current treatment approaches and new developments in myeloma therapies - New developments in stem cell transplantation to treat myeloma - Maintenance therapy updates for myeloma - Quality of life issues in the treatment of patients with myeloma]]></description>
      <pubDate>Thu, 08 Mar 2012 13:31:24 GMT</pubDate>
      <itunes:duration>01:20:06</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Speaker: Robert Z. Orlowski,MD, PhD; Topics Covered: - Goals of myeloma treatment - Current treatment approaches and new developments in myeloma therapies - New developments in stem cell transplantation to treat myeloma - Maintenance therapy updates for myeloma - Quality of life issues in the treatment of patients with myeloma</itunes:summary>
      <itunes:subtitle>Myeloma - Updates from the ASH Annual Meeting Spanish</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/c0c9c5f3-2e10-a816-cdcc-8ebe713842fd.mp3" type="audio/mpeg" length="19226146"/>
      <media:title>Myeloma - Updates from the ASH Annual Meeting Spanish</media:title>
      <media:text type="plain">Speaker: Robert Z. Orlowski,MD, PhD; Topics Covered: - Goals of myeloma treatment - Current treatment approaches and new developments in myeloma therapies - New developments in stem cell transplantation to treat myeloma - Maintenance therapy updates for myeloma - Quality of life issues in the treatment of patients with myeloma</media:text>
      <media:content url="http://lls.hipcast.com/deluge/c0c9c5f3-2e10-a816-cdcc-8ebe713842fd.mp3" type="audio/mpeg" fileSize="19226146" duration="4806"/>
      <link>http://lls.hipcast.com/deluge/c0c9c5f3-2e10-a816-cdcc-8ebe713842fd.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">8f187900-4912-8257-5f15-46d8df13aa88</guid>
      <title>Myeloma - Updates from the ASH® Annual Meeting Part 1</title>
      <description><![CDATA[Speaker: Robert Z. Orlowski,MD, PhD; Topics Covered: - Goals of myeloma treatment - Current treatment approaches and new developments in myeloma therapies - New developments in stem cell transplantation to treat myeloma - Maintenance therapy updates for myeloma - Quality of life issues in the treatment of patients with myeloma]]></description>
      <pubDate>Thu, 26 Jan 2012 17:27:10 GMT</pubDate>
      <itunes:duration>00:49:16</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Speaker: Robert Z. Orlowski,MD, PhD; Topics Covered: - Goals of myeloma treatment - Current treatment approaches and new developments in myeloma therapies - New developments in stem cell transplantation to treat myeloma - Maintenance therapy updates for myeloma - Quality of life issues in the treatment of patients with myeloma</itunes:summary>
      <itunes:subtitle>Myeloma - Updates from the ASH® Annual Meeting Part 1</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/9ed59e95-722e-01e8-0315-08346593681d.mp3" type="audio/mpeg" length="11825238"/>
      <media:title>Myeloma - Updates from the ASH® Annual Meeting Part 1</media:title>
      <media:text type="plain">Speaker: Robert Z. Orlowski,MD, PhD; Topics Covered: - Goals of myeloma treatment - Current treatment approaches and new developments in myeloma therapies - New developments in stem cell transplantation to treat myeloma - Maintenance therapy updates for myeloma - Quality of life issues in the treatment of patients with myeloma</media:text>
      <media:content url="http://lls.hipcast.com/deluge/9ed59e95-722e-01e8-0315-08346593681d.mp3" type="audio/mpeg" fileSize="11825238" duration="2956"/>
      <link>http://lls.hipcast.com/deluge/9ed59e95-722e-01e8-0315-08346593681d.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">8e190908-20d6-1e7c-029c-7b07e852db16</guid>
      <title>Myeloma - Updates from the ASH® Annual Meeting Part 2</title>
      <description><![CDATA[Speaker: Robert Z. Orlowski,MD, PhD; Topics Covered: - Goals of myeloma treatment - Current treatment approaches and new developments in myeloma therapies - New developments in stem cell transplantation to treat myeloma - Maintenance therapy updates for myeloma - Quality of life issues in the treatment of patients with myeloma]]></description>
      <pubDate>Thu, 26 Jan 2012 17:26:53 GMT</pubDate>
      <itunes:duration>00:38:36</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Speaker: Robert Z. Orlowski,MD, PhD; Topics Covered: - Goals of myeloma treatment - Current treatment approaches and new developments in myeloma therapies - New developments in stem cell transplantation to treat myeloma - Maintenance therapy updates for myeloma - Quality of life issues in the treatment of patients with myeloma</itunes:summary>
      <itunes:subtitle>Myeloma - Updates from the ASH® Annual Meeting Part 2</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/919c6a30-83da-8098-e77a-3eca65be71a7.mp3" type="audio/mpeg" length="9263880"/>
      <media:title>Myeloma - Updates from the ASH® Annual Meeting Part 2</media:title>
      <media:text type="plain">Speaker: Robert Z. Orlowski,MD, PhD; Topics Covered: - Goals of myeloma treatment - Current treatment approaches and new developments in myeloma therapies - New developments in stem cell transplantation to treat myeloma - Maintenance therapy updates for myeloma - Quality of life issues in the treatment of patients with myeloma</media:text>
      <media:content url="http://lls.hipcast.com/deluge/919c6a30-83da-8098-e77a-3eca65be71a7.mp3" type="audio/mpeg" fileSize="9263880" duration="2316"/>
      <link>http://lls.hipcast.com/deluge/919c6a30-83da-8098-e77a-3eca65be71a7.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">01b80a7b-06bb-f66d-00ca-0ac389705379</guid>
      <title>Myeloma - Expert Information Part 2</title>
      <description><![CDATA[Topics Covered:  - Signs and symptoms of myeloma; - Diagnosis and staging of myeloma; - Current and emerging treatments for myeloma; - The role of clinical trials in the advancement of myeloma treatment; - Quality of life issues for individuals living with myeloma]]></description>
      <pubDate>Thu, 03 Nov 2011 12:19:09 GMT</pubDate>
      <itunes:duration>00:24:53</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Topics Covered:  - Signs and symptoms of myeloma; - Diagnosis and staging of myeloma; - Current and emerging treatments for myeloma; - The role of clinical trials in the advancement of myeloma treatment; - Quality of life issues for individuals living with myeloma</itunes:summary>
      <itunes:subtitle>Myeloma - Expert Information Part 2</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/3e4aada5-8180-3e75-7b74-7956f5dc7931.mp3" type="audio/mpeg" length="5972869"/>
      <media:title>Myeloma - Expert Information Part 2</media:title>
      <media:text type="plain">Topics Covered:  - Signs and symptoms of myeloma; - Diagnosis and staging of myeloma; - Current and emerging treatments for myeloma; - The role of clinical trials in the advancement of myeloma treatment; - Quality of life issues for individuals living with myeloma</media:text>
      <media:content url="http://lls.hipcast.com/deluge/3e4aada5-8180-3e75-7b74-7956f5dc7931.mp3" type="audio/mpeg" fileSize="5972869" duration="1493"/>
      <link>http://lls.hipcast.com/deluge/3e4aada5-8180-3e75-7b74-7956f5dc7931.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">9bbf1bdc-c896-f358-aea6-aa42d5fa6d40</guid>
      <title>Myeloma - Expert Information Part 1</title>
      <description><![CDATA[Topics Covered:  - Signs and symptoms of myeloma; - Diagnosis and staging of myeloma; - Current and emerging treatments for myeloma; - The role of clinical trials in the advancement of myeloma treatment; - Quality of life issues for individuals living with myeloma]]></description>
      <pubDate>Thu, 03 Nov 2011 12:18:47 GMT</pubDate>
      <itunes:duration>01:05:50</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Topics Covered:  - Signs and symptoms of myeloma; - Diagnosis and staging of myeloma; - Current and emerging treatments for myeloma; - The role of clinical trials in the advancement of myeloma treatment; - Quality of life issues for individuals living with myeloma</itunes:summary>
      <itunes:subtitle>Myeloma - Expert Information Part 1</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/e74959f6-d36a-0307-9748-7d8781daf1df.mp3" type="audio/mpeg" length="15798776"/>
      <media:title>Myeloma - Expert Information Part 1</media:title>
      <media:text type="plain">Topics Covered:  - Signs and symptoms of myeloma; - Diagnosis and staging of myeloma; - Current and emerging treatments for myeloma; - The role of clinical trials in the advancement of myeloma treatment; - Quality of life issues for individuals living with myeloma</media:text>
      <media:content url="http://lls.hipcast.com/deluge/e74959f6-d36a-0307-9748-7d8781daf1df.mp3" type="audio/mpeg" fileSize="15798776" duration="3950"/>
      <link>http://lls.hipcast.com/deluge/e74959f6-d36a-0307-9748-7d8781daf1df.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">34d2c6a7-4b0e-ea42-f710-42128ca279c4</guid>
      <title>Advances in Myeloma Treatment and Side Effects Mgmt - Part 1</title>
      <description><![CDATA[Topics covered:
- Current and emerging treatment
- Myeloma treatment side effects
- The role of clinical trials
- Potential myeloma therapies
- Quality of life issues]]></description>
      <pubDate>Fri, 17 Jun 2011 18:34:43 GMT</pubDate>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Topics covered:&#13;
- Current and emerging treatment&#13;
- Myeloma treatment side effects&#13;
- The role of clinical trials&#13;
- Potential myeloma therapies&#13;
- Quality of life issues</itunes:summary>
      <itunes:subtitle>Advances in Myeloma Treatment and Side Effects Mgmt - Part 1</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <link>http://www.lls.org/#/resourcecenter/pastprograms/myeloma/041211_myeloma/</link>
    </item>
    <item>
      <guid isPermaLink="false">6adf2ee1-08ce-5259-8d8c-c6e213231714</guid>
      <title>Myeloma: Focus on Research and Emerging Therapies</title>
      <description><![CDATA[This program featured Robert Z. Orlowski, MD, PhD, Director, Myeloma Section, Associate Professor, Departments of Lymphoma/Myeloma and Experimental Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.]]></description>
      <pubDate>Wed, 09 Feb 2011 16:16:10 GMT</pubDate>
      <itunes:duration>01:32:12</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>This program featured Robert Z. Orlowski, MD, PhD, Director, Myeloma Section, Associate Professor, Departments of Lymphoma/Myeloma and Experimental Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.</itunes:summary>
      <itunes:subtitle>Myeloma: Focus on Research and Emerging Therapies</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/8e1c7907-5bb5-50f9-e410-3643980e2e26.mp3" type="audio/mpeg" length="22129290"/>
      <media:title>Myeloma: Focus on Research and Emerging Therapies</media:title>
      <media:text type="plain">This program featured Robert Z. Orlowski, MD, PhD, Director, Myeloma Section, Associate Professor, Departments of Lymphoma/Myeloma and Experimental Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.</media:text>
      <media:content url="http://lls.hipcast.com/deluge/8e1c7907-5bb5-50f9-e410-3643980e2e26.mp3" type="audio/mpeg" fileSize="22129290" duration="5532"/>
      <link>http://lls.hipcast.com/deluge/8e1c7907-5bb5-50f9-e410-3643980e2e26.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">eb26829c-4165-0335-4db8-7a47181d29de</guid>
      <title>Understanding Myeloma Diagnosis and Treatment - Part 2</title>
      <description><![CDATA[November 4, 2010

Understanding Myeloma Diagnosis and Treatment
Part 2 - Q&A

This program featured Paul G. Richardson, MD, Associate Professor of Medicine, Harvard Medical School, Clinical Director, Jerome Lipper Center for Multiple Myeloma, Dana-Farber Cancer Institute, Boston, MA.

This program was sponsored by The Leukemia & Lymphoma Society and supported by grants from Celgene Corporation and Millennium: The Takeda Oncology Company.

Program Slides: http://www.leukemia-lymphoma.org/graphics/National/DrRichardsonsslides11410.pdf]]></description>
      <pubDate>Fri, 19 Nov 2010 21:53:28 GMT</pubDate>
      <itunes:duration>00:30:50</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>November 4, 2010&#13;
&#13;
Understanding Myeloma Diagnosis and Treatment&#13;
Part 2 - Q&amp;A&#13;
&#13;
This program featured Paul G. Richardson, MD, Associate Professor of Medicine, Harvard Medical School, Clinical Director, Jerome Lipper Center for Multiple Myeloma, Dana-Farber Cancer Institute, Boston, MA.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by grants from Celgene Corporation and Millennium: The Takeda Oncology Company.&#13;
&#13;
Program Slides: http://www.leukemia-lymphoma.org/graphics/National/DrRichardsonsslides11410.pdf</itunes:summary>
      <itunes:subtitle>Understanding Myeloma Diagnosis and Treatment - Part 2</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/cbbaa1e6-8c77-ea99-9635-1ebe7c567381.mp3" type="audio/mpeg" length="7402081"/>
      <media:title>Understanding Myeloma Diagnosis and Treatment - Part 2</media:title>
      <media:text type="plain">November 4, 2010&#13;
&#13;
Understanding Myeloma Diagnosis and Treatment&#13;
Part 2 - Q&amp;A&#13;
&#13;
This program featured Paul G. Richardson, MD, Associate Professor of Medicine, Harvard Medical School, Clinical Director, Jerome Lipper Center for Multiple Myeloma, Dana-Farber Cancer Institute, Boston, MA.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by grants from Celgene Corporation and Millennium: The Takeda Oncology Company.&#13;
&#13;
Program Slides: http://www.leukemia-lymphoma.org/graphics/National/DrRichardsonsslides11410.pdf</media:text>
      <media:content url="http://lls.hipcast.com/deluge/cbbaa1e6-8c77-ea99-9635-1ebe7c567381.mp3" type="audio/mpeg" fileSize="7402081" duration="1850"/>
      <link>http://lls.hipcast.com/deluge/cbbaa1e6-8c77-ea99-9635-1ebe7c567381.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">5343f5e3-929f-50b5-4543-eae467bb3172</guid>
      <title>Understanding Myeloma Diagnosis and Treatment - Part 1</title>
      <description><![CDATA[November 4, 2010

Understanding Myeloma Diagnosis and Treatment
Part 1 - Presentation

This program featured Paul G. Richardson, MD, Associate Professor of Medicine, Harvard Medical School, Clinical Director, Jerome Lipper Center for Multiple Myeloma, Dana-Farber Cancer Institute, Boston, MA.

This program was sponsored by The Leukemia & Lymphoma Society and supported by grants from Celgene Corporation and Millennium: The Takeda Oncology Company.

Program Slides: http://www.leukemia-lymphoma.org/graphics/National/DrRichardsonsslides11410.pdf]]></description>
      <pubDate>Fri, 19 Nov 2010 21:52:49 GMT</pubDate>
      <itunes:duration>00:54:14</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>November 4, 2010&#13;
&#13;
Understanding Myeloma Diagnosis and Treatment&#13;
Part 1 - Presentation&#13;
&#13;
This program featured Paul G. Richardson, MD, Associate Professor of Medicine, Harvard Medical School, Clinical Director, Jerome Lipper Center for Multiple Myeloma, Dana-Farber Cancer Institute, Boston, MA.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by grants from Celgene Corporation and Millennium: The Takeda Oncology Company.&#13;
&#13;
Program Slides: http://www.leukemia-lymphoma.org/graphics/National/DrRichardsonsslides11410.pdf</itunes:summary>
      <itunes:subtitle>Understanding Myeloma Diagnosis and Treatment - Part 1</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/6e0e038d-3ebd-63b0-b5cf-0c627236265f.mp3" type="audio/mpeg" length="13016526"/>
      <media:title>Understanding Myeloma Diagnosis and Treatment - Part 1</media:title>
      <media:text type="plain">November 4, 2010&#13;
&#13;
Understanding Myeloma Diagnosis and Treatment&#13;
Part 1 - Presentation&#13;
&#13;
This program featured Paul G. Richardson, MD, Associate Professor of Medicine, Harvard Medical School, Clinical Director, Jerome Lipper Center for Multiple Myeloma, Dana-Farber Cancer Institute, Boston, MA.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by grants from Celgene Corporation and Millennium: The Takeda Oncology Company.&#13;
&#13;
Program Slides: http://www.leukemia-lymphoma.org/graphics/National/DrRichardsonsslides11410.pdf</media:text>
      <media:content url="http://lls.hipcast.com/deluge/6e0e038d-3ebd-63b0-b5cf-0c627236265f.mp3" type="audio/mpeg" fileSize="13016526" duration="3254"/>
      <link>http://lls.hipcast.com/deluge/6e0e038d-3ebd-63b0-b5cf-0c627236265f.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">c4af4134-19ba-f068-a17f-cab98e118d80</guid>
      <title>Getting the Answers You Need: Fatigue and Other Cancer Treatment</title>
      <description><![CDATA[Getting the Answers You Need: Fatigue and Other Cancer Treatment
October 20, 2010

This young adult program featured Owen Applequist, NHL/Hodgkin Survivor, Michael G. Douvas, MD, Assistant Professor of Medicine, Hematology/Oncology Division, University of Virginia Health System; Jeanne M. Erickson, PhD, RN, AOCN, Robert's Scholar, Assistant Professor, University of Virginia School of Nursing and Clare Karten, MS, Sr. Director of Mission Education, The Leukemia & Lymphoma Society.

This program was sponsored by The Leukemia & Lymphoma Society and supported by a grant from Genentech and Biogen Idec.

Download the program slides that accompany this event here: http://www.lls.org/graphics/National/YAconnectPPTslides1020FINAL.pdf]]></description>
      <pubDate>Wed, 03 Nov 2010 19:25:43 GMT</pubDate>
      <itunes:duration>00:56:55</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Getting the Answers You Need: Fatigue and Other Cancer Treatment&#13;
October 20, 2010&#13;
&#13;
This young adult program featured Owen Applequist, NHL/Hodgkin Survivor, Michael G. Douvas, MD, Assistant Professor of Medicine, Hematology/Oncology Division, University of Virginia Health System; Jeanne M. Erickson, PhD, RN, AOCN, Robert's Scholar, Assistant Professor, University of Virginia School of Nursing and Clare Karten, MS, Sr. Director of Mission Education, The Leukemia &amp; Lymphoma Society.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by a grant from Genentech and Biogen Idec.&#13;
&#13;
Download the program slides that accompany this event here: http://www.lls.org/graphics/National/YAconnectPPTslides1020FINAL.pdf</itunes:summary>
      <itunes:subtitle>Getting the Answers You Need: Fatigue and Other Cancer Treatment</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/6c768f9e-e4dd-38fb-e51d-2028d0285619.mp3" type="audio/mpeg" length="13659975"/>
      <media:title>Getting the Answers You Need: Fatigue and Other Cancer Treatment</media:title>
      <media:text type="plain">Getting the Answers You Need: Fatigue and Other Cancer Treatment&#13;
October 20, 2010&#13;
&#13;
This young adult program featured Owen Applequist, NHL/Hodgkin Survivor, Michael G. Douvas, MD, Assistant Professor of Medicine, Hematology/Oncology Division, University of Virginia Health System; Jeanne M. Erickson, PhD, RN, AOCN, Robert's Scholar, Assistant Professor, University of Virginia School of Nursing and Clare Karten, MS, Sr. Director of Mission Education, The Leukemia &amp; Lymphoma Society.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by a grant from Genentech and Biogen Idec.&#13;
&#13;
Download the program slides that accompany this event here: http://www.lls.org/graphics/National/YAconnectPPTslides1020FINAL.pdf</media:text>
      <media:content url="http://lls.hipcast.com/deluge/6c768f9e-e4dd-38fb-e51d-2028d0285619.mp3" type="audio/mpeg" fileSize="13659975" duration="3415"/>
      <link>http://lls.hipcast.com/deluge/6c768f9e-e4dd-38fb-e51d-2028d0285619.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">40a75351-689b-b370-0543-170ae9c7e9cb</guid>
      <title>Navigating Employment and Insurance</title>
      <description><![CDATA[June 30, 2010

Navigating Employment and Insurance

This young adult program featured Jeremy Katzman, Leukemia Survivor, Cyndy Sotomayor, Lymphoma Survivor, Joanna L. Fawzy Morales, Esq. Director, Cancer Legal Resource Center, Adjunct Professor of Law, Loyola Law School and Gina Russo, LCSW, Director, Information Resource Center, The Leukemia & Lymphoma Society.

This program was sponsored by The Leukemia & Lymphoma Society and supported by a grant from Genentech and Biogen Idec.

Program slides: http://www.leukemia-lymphoma.org/graphics/National/Resources_slides_6_28_10_with_footer.ppt]]></description>
      <pubDate>Fri, 16 Jul 2010 18:22:07 GMT</pubDate>
      <itunes:duration>00:51:40</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>June 30, 2010&#13;
&#13;
Navigating Employment and Insurance&#13;
&#13;
This young adult program featured Jeremy Katzman, Leukemia Survivor, Cyndy Sotomayor, Lymphoma Survivor, Joanna L. Fawzy Morales, Esq. Director, Cancer Legal Resource Center, Adjunct Professor of Law, Loyola Law School and Gina Russo, LCSW, Director, Information Resource Center, The Leukemia &amp; Lymphoma Society.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by a grant from Genentech and Biogen Idec.&#13;
&#13;
Program slides: http://www.leukemia-lymphoma.org/graphics/National/Resources_slides_6_28_10_with_footer.ppt</itunes:summary>
      <itunes:subtitle>A Young Adult Webcast</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/980fc7cd-1075-a86f-61da-6aac0ac2ac77.mp3" type="audio/mpeg" length="12399096"/>
      <media:title>Navigating Employment and Insurance</media:title>
      <media:text type="plain">June 30, 2010&#13;
&#13;
Navigating Employment and Insurance&#13;
&#13;
This young adult program featured Jeremy Katzman, Leukemia Survivor, Cyndy Sotomayor, Lymphoma Survivor, Joanna L. Fawzy Morales, Esq. Director, Cancer Legal Resource Center, Adjunct Professor of Law, Loyola Law School and Gina Russo, LCSW, Director, Information Resource Center, The Leukemia &amp; Lymphoma Society.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by a grant from Genentech and Biogen Idec.&#13;
&#13;
Program slides: http://www.leukemia-lymphoma.org/graphics/National/Resources_slides_6_28_10_with_footer.ppt</media:text>
      <media:content url="http://lls.hipcast.com/deluge/980fc7cd-1075-a86f-61da-6aac0ac2ac77.mp3" type="audio/mpeg" fileSize="12399096" duration="3100"/>
      <link>http://lls.hipcast.com/deluge/980fc7cd-1075-a86f-61da-6aac0ac2ac77.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">204e92d1-e8fd-8c54-9174-8d209e734447</guid>
      <title>Partners in Progress: An Expert Panel Discussion - Part 2</title>
      <description><![CDATA[June 22, 2010 - Part 2

Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers

This program featured Gail J. Roboz, MD, Director, Leukemia Program, Associate Professor of Medicine and Maria Baldo, MS, PA-C, Senior Physician Assistant, Leukemia Service both from Weill Cornell Medical College of Cornell University in New York and Stuart L. Goldberg, MD, Chief, Division of Leukemia, John Theurer Cancer Center, Hackensack University Medical Center, Associate Clinical Professor of Medicine, University of Medicine & Dentistry of New Jersey and Louis J. DeGennaro, PhD, Executive Vice President and Chief Mission Officer, The Leukemia & Lymphoma Society, White Plains, New York and John J. Hughes, MDS Survivor and Clinical Trial Participant from Bayonne, New Jersey.
 
This program was sponsored by The Leukemia & Lymphoma Society and supported by an educational grant from Genentech and Biogen Idec and also supported by an educational donation from Amgen.]]></description>
      <pubDate>Fri, 09 Jul 2010 16:10:20 GMT</pubDate>
      <itunes:duration>00:59:54</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>June 22, 2010 - Part 2&#13;
&#13;
Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers&#13;
&#13;
This program featured Gail J. Roboz, MD, Director, Leukemia Program, Associate Professor of Medicine and Maria Baldo, MS, PA-C, Senior Physician Assistant, Leukemia Service both from Weill Cornell Medical College of Cornell University in New York and Stuart L. Goldberg, MD, Chief, Division of Leukemia, John Theurer Cancer Center, Hackensack University Medical Center, Associate Clinical Professor of Medicine, University of Medicine &amp; Dentistry of New Jersey and Louis J. DeGennaro, PhD, Executive Vice President and Chief Mission Officer, The Leukemia &amp; Lymphoma Society, White Plains, New York and John J. Hughes, MDS Survivor and Clinical Trial Participant from Bayonne, New Jersey.&#13;
 &#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by an educational grant from Genentech and Biogen Idec and also supported by an educational donation from Amgen.</itunes:summary>
      <itunes:subtitle>Partners in Progress: An Expert Panel Discussion - Part 2</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/aebb9375-46e9-19fc-8536-b44daa0d4e65.mp3" type="audio/mpeg" length="14377715"/>
      <media:title>Partners in Progress: An Expert Panel Discussion - Part 2</media:title>
      <media:text type="plain">June 22, 2010 - Part 2&#13;
&#13;
Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers&#13;
&#13;
This program featured Gail J. Roboz, MD, Director, Leukemia Program, Associate Professor of Medicine and Maria Baldo, MS, PA-C, Senior Physician Assistant, Leukemia Service both from Weill Cornell Medical College of Cornell University in New York and Stuart L. Goldberg, MD, Chief, Division of Leukemia, John Theurer Cancer Center, Hackensack University Medical Center, Associate Clinical Professor of Medicine, University of Medicine &amp; Dentistry of New Jersey and Louis J. DeGennaro, PhD, Executive Vice President and Chief Mission Officer, The Leukemia &amp; Lymphoma Society, White Plains, New York and John J. Hughes, MDS Survivor and Clinical Trial Participant from Bayonne, New Jersey.&#13;
 &#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by an educational grant from Genentech and Biogen Idec and also supported by an educational donation from Amgen.</media:text>
      <media:content url="http://lls.hipcast.com/deluge/aebb9375-46e9-19fc-8536-b44daa0d4e65.mp3" type="audio/mpeg" fileSize="14377715" duration="3594"/>
      <link>http://lls.hipcast.com/deluge/aebb9375-46e9-19fc-8536-b44daa0d4e65.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">5291525e-65f8-d295-424a-1b2741154dcf</guid>
      <title>Partners in Progress: An Expert Panel Discussion - Part 1</title>
      <description><![CDATA[June 22, 2010 - Part 1

Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers

This program featured Gail J. Roboz, MD, Director, Leukemia Program, Associate Professor of Medicine and Maria Baldo, MS, PA-C, Senior Physician Assistant, Leukemia Service both from Weill Cornell Medical College of Cornell University in New York and Stuart L. Goldberg, MD, Chief, Division of Leukemia, John Theurer Cancer Center, Hackensack University Medical Center, Associate Clinical Professor of Medicine, University of Medicine & Dentistry of New Jersey and Louis J. DeGennaro, PhD, Executive Vice President and Chief Mission Officer, The Leukemia & Lymphoma Society, White Plains, New York and John J. Hughes, MDS Survivor and Clinical Trial Participant from Bayonne, New Jersey.
 
This program was sponsored by The Leukemia & Lymphoma Society and supported by an educational grant from Genentech and Biogen Idec and also supported by an educational donation from Amgen.]]></description>
      <pubDate>Fri, 09 Jul 2010 16:09:44 GMT</pubDate>
      <itunes:duration>00:53:18</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>June 22, 2010 - Part 1&#13;
&#13;
Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers&#13;
&#13;
This program featured Gail J. Roboz, MD, Director, Leukemia Program, Associate Professor of Medicine and Maria Baldo, MS, PA-C, Senior Physician Assistant, Leukemia Service both from Weill Cornell Medical College of Cornell University in New York and Stuart L. Goldberg, MD, Chief, Division of Leukemia, John Theurer Cancer Center, Hackensack University Medical Center, Associate Clinical Professor of Medicine, University of Medicine &amp; Dentistry of New Jersey and Louis J. DeGennaro, PhD, Executive Vice President and Chief Mission Officer, The Leukemia &amp; Lymphoma Society, White Plains, New York and John J. Hughes, MDS Survivor and Clinical Trial Participant from Bayonne, New Jersey.&#13;
 &#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by an educational grant from Genentech and Biogen Idec and also supported by an educational donation from Amgen.</itunes:summary>
      <itunes:subtitle>Partners in Progress: An Expert Panel Discussion - Part 1</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/2b92886f-90b9-50f5-3401-517ec2b923c2.mp3" type="audio/mpeg" length="12792605"/>
      <media:title>Partners in Progress: An Expert Panel Discussion - Part 1</media:title>
      <media:text type="plain">June 22, 2010 - Part 1&#13;
&#13;
Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers&#13;
&#13;
This program featured Gail J. Roboz, MD, Director, Leukemia Program, Associate Professor of Medicine and Maria Baldo, MS, PA-C, Senior Physician Assistant, Leukemia Service both from Weill Cornell Medical College of Cornell University in New York and Stuart L. Goldberg, MD, Chief, Division of Leukemia, John Theurer Cancer Center, Hackensack University Medical Center, Associate Clinical Professor of Medicine, University of Medicine &amp; Dentistry of New Jersey and Louis J. DeGennaro, PhD, Executive Vice President and Chief Mission Officer, The Leukemia &amp; Lymphoma Society, White Plains, New York and John J. Hughes, MDS Survivor and Clinical Trial Participant from Bayonne, New Jersey.&#13;
 &#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by an educational grant from Genentech and Biogen Idec and also supported by an educational donation from Amgen.</media:text>
      <media:content url="http://lls.hipcast.com/deluge/2b92886f-90b9-50f5-3401-517ec2b923c2.mp3" type="audio/mpeg" fileSize="12792605" duration="3198"/>
      <link>http://lls.hipcast.com/deluge/2b92886f-90b9-50f5-3401-517ec2b923c2.mp3</link>
    </item>
  </channel>
</rss>
